The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase 2 trial of cediranib alone or cediranib plus lenalidomide in iodine 131-refractory differentiated thyroid cancer (DTC): A University of Chicago Phase 2 Consortium trial.
 
Jonas A. De Souza
Speakers' Bureau - AstraZeneca
 
Theodore Karrison
No Relationships to Disclose
 
Bernadette Libao
No Relationships to Disclose
 
Francis P. Worden
Honoraria - Bayer
Consulting or Advisory Role - Bayer/Onyx
Travel, Accommodations, Expenses - Bayer/Onyx
 
Monika Krzyzanowska
No Relationships to Disclose
 
David N. Hayes
Leadership - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Consulting or Advisory Role - GeneCentric
Patents, Royalties, Other Intellectual Property - I hold several diagnostic patents or pending patents in the area of solid tumor diagnostics
 
Eric Winquist
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis (Inst); Medivation (Inst); Oncogenex (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Vassiliki Saloura
No Relationships to Disclose
 
Victoria Meucci Villaflor
No Relationships to Disclose
 
Tanguy Y. Seiwert
Honoraria - Amgen; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Merck; Merck Serono
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)
 
Walter Michael Stadler
Honoraria - Bayer; CVS Caremark; Johnson & Johnson; medpacto; Merck; Sotio
Consulting or Advisory Role - Bayer; CVS Caremark; Johnson & Johnson; medpacto; Merck; Sotio
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst)
Other Relationship - UpToDate
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis
Speakers' Bureau - Bayer; Eisai
 
Rebecca B. Schechter
No Relationships to Disclose
 
Everett E. Vokes
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Lilly